China may buy $90 billion more US goods, says Morgan Stanley
China will likely seek a ‘non-disruptive approach’ to reducing its record trade surplus with the US by gradually increasing the share of additional goods imported from there
Beijing: China will buy an additional $60 billion to $90 billion worth of American goods over the next several years, with agricultural products poised to benefit in the near term followed by energy and ultimately non-high-tech manufactured products, according to Morgan Stanley.
The world’s largest trading nation will likely seek a “non-disruptive approach” to reducing its record trade surplus with the US by gradually increasing the share of additional goods imported from there, Hong Kong-based economists Robin Xing and Jenny Zheng wrote in a report this week. Other economists say China will have to divert imports from other nations.
China’s imports increased by $255 billion, or 16%, to $1.84 trillion last year, customs administration data show. Incoming shipments from the US rose by $20 billion, accounting for less than 8% of the total gain.
Boosting goods imports from the US by more than $90 billion could require Washington to relax controls on high-tech exports to China, “an option in which the US has appeared to show little interest in the current trade talks,” Xing and Zheng wrote.
The White House said in recent days China had offered to cut its trade surplus with the US by at least $200 billion, a number Beijing cast doubt on. It’s unrealistic for China to make such a boost to purchases over two years because it would distort its trading position with other nations and erode its already slipping current account surplus, Xing and Zheng said.
- Write-offs at PSBs grow at faster clip than loan growth
- Monetary policy panel cites inflationary risks as reason for RBI rate hike
- Vivo invests ₹200 crore to ramp up manufacturing at Greater Noida facility
- Ad agency Rediffusion to launch new logo, vision
- CSIR lab develops potential clot buster drug for stroke, licences it for clinical trials
Editor's Picks »
- At opposition meet, Rahul Gandhi targets govt over Rafale deal
- News in numbers: Trump’s attacks on the press ‘dangerous to the lifeblood of democracy’, says NYT
- Former Religare CEO Shachindra Nath raises about ₹1,000 crore for NBFC
- PE industry lobbies CCI for anti-trust exemptions
- Opinion | Turkey flashes warning sign to Asia
- Recent rise in trade deficit is not due to the oil prices
- Safeguard duty proposal has deepened uncertainty in the solar energy sector
- Fortis Healthcare: What now, after IHH entry and June quarter loss?
- Weak Q1 for Amara Raja but investors pin hopes on softening lead prices
- IDBI Bank Q1 results show how expensive it is for LIC